ABT vs. SWTX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and SWTX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing SWTX’s 3.48 billion USD by roughly 66.51×.
With betas of 0.74 for ABT and 0.77 for SWTX, both show similar volatility profiles relative to the overall market.
| Symbol | ABT | SWTX |
|---|---|---|
| Company Name | Abbott Laboratories | SpringWorks Therapeutics, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Biotechnology |
| CEO | Mr. Robert B. Ford | Mr. Saqib Islam J.D. |
| Price | 133.05 USD | 46.21 USD |
| Market Cap | 231.49 billion USD | 3.48 billion USD |
| Beta | 0.74 | 0.77 |
| Exchange | NYSE | NASDAQ |
| IPO Date | March 17, 1980 | September 13, 2019 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and SWTX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ABT and SWTX based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- SWTX shows a negative P/E of -13.63, highlighting a year of losses, whereas ABT at 17.22 trades on solid profitability.
- SWTX shows a negative forward PEG of -6.77, signaling expected earnings contraction, while ABT at 1.73 maintains analysts’ projections for stable or improved profits.
- SWTX reports a negative Price-to-Free Cash Flow ratio of -19.97, showing a cash flow shortfall that could threaten its operational sustainability, while ABT at 34.77 maintains positive cash flow.
| Symbol | ABT | SWTX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | -13.63 |
| Forward PEG Ratio (TTM) | 1.73 | -6.77 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 15.84 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 8.29 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | -19.97 |
| EV-to-EBITDA (TTM) | 22.97 | -13.07 |
| EV-to-Sales (TTM) | 5.63 | 15.59 |
| EV-to-Free Cash Flow (TTM) | 35.78 | -19.64 |
Dividend Comparison
ABT delivers a 1.71% dividend yield, blending income with growth, whereas SWTX appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.
| Symbol | ABT | SWTX |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 0.00% |
Financial Strength Metrics Comparison
Explore the financial strength details for ABT and SWTX in the table below.
| Symbol | ABT | SWTX |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 4.33 |
| Quick Ratio (TTM) | 1.27 | 4.18 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 0.02 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.01 |
| Interest Coverage Ratio (TTM) | 15.39 | 265.27 |